I definitely have the source technology to produce tailored embryonic stem cells. I can replicate the process anytime.

I would like to have time to confirm the validity of the technology.

Our research team made patient-specific embryonic stem cells and we have the technology to produce them.

Technology for patient-specific embryonic stem cells belongs to South Korea. And you will find out that this is true.

There is no doubt that we produced 11 patient-specific stem cells and possess the core technology to create them again.

I sincerely apologize to the nation for using erroneous data in the papers.